Tumor necrosis factor α and interleukin 1β are responsible for in vitro myocardial cell depression induced by human septic shock serum

Journal of Experimental Medicine

Volumn 183, Issue 3, 1996, Pages 949-958

  Kumar, Anand ^a   Thota, Venkateswarlu ^a   Dee, Linda ^a   Olson, Jeanne ^a   Uretz, Eugene ^a   Parrillo, Joseph E ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; GAMMA INTERFERON; HEART MUSCLE DEPRESSANT FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE EXCITABILITY; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; IMMUNOREGULATION; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SEPTIC SHOCK; VIDEORECORDING;

ANIMALS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; HUMANS; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-1; INTERLEUKINS; KINETICS; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; RATS; RATS, INBRED LEW; RECOMBINANT PROTEINS; SHOCK, SEPTIC; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029975877     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.3.949     Document Type: Article

References (44)

1. Parker, M.M., K.E. McCarthy, F.P. Ognibene, and J.E. Parrillo. 1990. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest. 97:126-131.
2. Parker, M.M., J.H. Shelhamer, S.L. Bacharach, M.V. Green, C. Natanson, T.M. Frederick, B.A. Damske, and J.E. Parrillo. 1984. Profound but reversible myocardial depression in patients with septic shock. Ann. Intern. Med. 100:483-490.
3. Ellrodt, A.G., M.S. Riedinger, A. Kimchi, D.S. Berman, J. Maddahi, H.J.C. Swan, and G.H. Murata. 1985. Left ventricular performance in septic shock: reversible segmental and global abnormalities. Am. Heart J. 110:402-409.
4. Reilly, J.M., R.E. Cunnion, C. Burch-Whitman, M.M. Parker, J.H. Shelhamer, and J.E. Parrillo. 1989. A circulating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (lactic acidemia) in patients with septic shock. Chest. 95:1072-1080.
5. Schuette, W.H., C. Burch, P.O. Roach, and J.E. Parrillo. 1987. Closed loop television tracking of bearing heart cells in vitro. Cytometry. 8:101-103.
6. Parrillo, J.E., C. Burch, J.H. Shelhamer, M.M. Parker, C. Natanson, and W. Schuette. 1985. A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J. Clin. Invest. 76:1539-1553.
7. Parrillo, J.E., M.M. Parker, C. Natanson, A.F. Suffredini, R.L. Danner, R.E. Cunnion, and F.P. Ognibene. 1990. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann. Intern. Med 113:227-242.
8. Parrillo, J.E. 1993. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328:1471-1477.
9. Jha, P., H. Jacobs, D. Bose, R. Wang, J. Yang, R.B. Light, and S. Mink. 1993. Effects of E. coli sepsis and myocardial depressant factor on interval-force relations in dog ventricle. Am. J. Physiol. 264:H1402-H1410.
10. Harary, I., and B. Farley. 1960. In-vitro studies of single isolated beating rat heart cells. Science (Wash. DC). 131:1674-1675.
11. Casey, L.C., R.A. Balk, and R.C. Bone. 1993. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 119:771-778.
12. Danner, R.L., R.J. Elin, J.M. Hosseini, R.A. Wesley, J.M. Reilly, and J.E. Parrillo. 1991. Endotoxemia in human septic shock. Chest. 99:169-175.
13. Hospenud, J.D. 1993. The effects of interleukin 1 on myocardial function and metabolism. Clin. Immunol. Immunopathol. 68:175-180.
14. Yokoyama, T., L. Vaca, R.D. Rossen, W. Durante, P. Hazarika, and D.L. Mann. 1993. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin. Invest. 92:2303-2312.
15. Waage, A., P. Brandtzaeg, A. Halstensen, P. Kierulf, and T. Espevik. 1989. The complex pattern of cytokines in serum from patients with meningococcal septic shock. J. Exp. Med. 169:333-338.
16. Finkel, M.S., C.V. Oddis, T.D. Jacobs, S.C. Watkins, B.G. Hattler, and R.L. Simmons. 1992. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science (Wash. DC). 257:387-389.
17. Girardin, E., G.E. Grau, J.M. Dayer, P. Roux-Lombard, and P.H. Lambert. 1989. Plasma tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N. Engl. J. Med. 319:397-400.
18. Gulick, T., M.K. Chung, S.J. Pieper, L.G. Lange, and G.F. Schreiner. 1989. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte adrenergic responsiveness. Proc. Natl. Acad. Sci. USA. 86:6753-6757.
19. Balligand, J., D. Ungureanu, R.A. Kelly, L. Kobzik, D. Pimental, T. Michel, and T.W. Smith. 1993. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J. Clin. Invest. 91:2314-2319.
20. Weinberg, J.R., P. Boyle, A. Meager, and A. Guz. 1992. Lipopolysaccharide, tumor necrosis factor, and interleukin-1 interact to cause hypotension. J. Lab. Clin. Med. 120:205-211.
21. Okusawa, S., J.A. Gelfand, T. Ikejima, R.J. Connolly, and C.A. Dinarello. 1988. Interleukin-1 induces a shock like state in rabbits. J. Clin. Invest. 81:1162-1172.
22. Waage, A., and T. Espevik. 1988. Interleukin-1 potentiates the lethal effect of tumor necrosis factor α/cachectin in mice. J. Exp. Med. 167:1987-1992.
23. Natanson, C., M.P. Fink, H.K. Ballantyne, T.J. MacVittie, J.J. Conklin, and J.E. Parrillo. 1986. Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J. Clin. Invest. 78:259-270.
24. Goldfarb, R.D., L.M. Nightingale, P. Kish, P.B. Weber, and D.J. Loegering. 1986. Left ventricular function during lethal and sublethal endotoxemia in swine. Am. J. Physiol. 251: H364-H373.
25. Lefer, A.M., and J. Martin. 1970. Origin of myocardial depressant factor in shock. Am. J. Physiol. 218:1423-1427.
26. Wangensteen, S.L., W.T. Geissenger, W.L. Lovett, T.M. Glenn, and A.M. Lefer. 1971. Relationship between splanchnic blood flow and a myocardial depressant factor in endotoxin shock. Surgery (St. Louis). 69:410-418.
27. Lovett, W.L., S.L. Wangensteen, T.M. Glenn, and A.M. Lefer. 1971. Presence of a myocardial depressant factor in patients with circulatory shock. Surgery (St. Louis). 70:223-231.
28. McConn, R., J.K. Greineder, F. Wasserman, and G.H.A. Clowes. 1979. Is there a humoral factor that depresses ventricular function in sepsis? Circ. Shock. 1:9-22.
29. Carli, A., M.C. Auclair, C. Vernimmen, and P. Jourdon. 1979. Reversal by calcium of rat heart cell dysfunction induced by human sera in septic shock. Circ. Shock. 6:147-157.
30. Benassayag, C., M.C. Christeff, M.C. Auclair, C. Vernimmen, C. Carli-Vielle, E. Nunez, and A. Carli. 1984. Early released lipid-soluble cardiodepressant factor and elevated oestrogenic substances in human septic shock. Eur. J. Clin. Invest. 14:288-294.
31. 2+], and cell contraction in cultured chick ventricular myocytes. Circ. Res. 75:285-295.
32. Weisensee, D., J. Bereiter-Hahn, W. Schoeppe, and I. Low-Friedrich. 1993. Effects of cytokines on the contractility of cultured cardiac myocytes. Int. J. Immunopharmacol. 15:581-587.
33. Chung, M.K., T.S. Gulick, R.E. Rotondo, G.F. Schreiner, and L.G. Lange. 1990. Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myoctyes: impairment of signal transduction. Circ. Res. 67:753-763.
34. 2+)-independent nitric oxide synchase in the myocardium. Br. J. Pharmacol. 105:575-580.
35. Schulz, R., D.L. Panas, S. Moncada, P.M. Olley, and G.D. Lopaschuk. 1992. Depression of cardiac function in cytokine treated hearts is diminished by inhibition of nitric oxide synthesis and abolished by dexamethasone. Circulation. 86:1295. (Abstr.)
36. Evans, H.G., M.J. Lewis, and A.M. Shah. 1993. Interleukin-1 beta modulates myocardial contraction via dexamethasone sensitive production of nitric oxide. Cardiovasc. Res. 27:1486-1490.
37. Natanson, C., R.L. Danner, M.P. Fink, T.J. MacVittie, R.I. Walker, J.J. Conklin, and J.E. Parrillo. 1988. Cardiovascular performance with E. coli challenges in a canine model of human sepsis. Am. J. Physiol. 254:H558-H569.
38. Eichenholz, P.W., P.Q. Eichacker, W.D. Hoffman, S.M. Banks, J.E. Parrillo, R.L. Danner, and C. Natanson. 1992. Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction. Am. J. Physiol. 263:H668-H675.
39. Natanson, C., P.W. Eichenholz, R.L. Danner, P.Q. Eichacker, W.D. Hoffman, G.C Kuo, S.M. Banks, T.J. MacVittie, and J.E. Parrillo. 1989. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J. Exp. Med. 169:823-832.
40. Walley, K.R., P.C. Hebert, Y. Wakai, P.G. Wilcox, J.D. Road, and D.J. Cooper. 1994. Decrease in left ventricular contractility after tumor necrosis factor-alpha infusion in dogs. J. Appl. Physiol. 76:1060-1067.
41. Roberts, A.B., Y. Vodovotz, N.S. Roche, M.B. Sporn, and C.F. Nathan. 1992. Role of nitric oxide in antagonistic effects of transforming growth factor-beta and interleukin-1 beta on the beating rate of cultured cardiac myocytes. Mol. Endocrinol. 6:1921-1930.
42. Salvemini, D., R. Korbut, E. Anggard, and J.R. Vane. 1990. Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci USA. 87:2593-2597.
43. Kumar, A., R. Kosuri, P. Kandula, L. Lakshminarayanan, E. Bunnell, L Dee, J. Olson, E. Uretz, and J.E. Parrillo. 1994. Interleukin-1 beta but not endotoxin, interferon-gamma, or interleukin-6 depresses myocardial cell contractility in-vitro. Clin. Res. 42:168a. (Abstr.)
44. Stemmer, P., P.L. Wisler, and A.M. Watanabe. 1991. Isolated myocytes in experimental cardiology. In The Heart and Cardiovascular System. Scientific Foundations. H.A. Fozzard, E. Haber, R.B. Jennings, A.M. Katz, and H.E. Morgan, editors. Raven Press, New York. 387-404.